Precision System Science Co Stock

Precision System Science Co Equity

The The Equity of Precision System Science Co (7707.T) as of Jul 22, 2026 is 3.76 B JPY. In the previous year, The Equity was 4.14 B JPY — a change of -9.22% (lower).

Equity

3.76 BJPY

YoY

-9.22%

Last updated:

In 2026, Precision System Science Co's equity was 3.76 B JPY, a -9.22% increase from the 4.14 B JPY equity in the previous year.

Access this data via the Eulerpool API

Precision System Science Co Stock analysis

What does Precision System Science Co do? Precision System Science Co Ltd is a leading company in the field of medical research and diagnostics, founded in Japan in 1989. The company is headquartered in Chiba, Japan and operates branches in Europe, the USA, and Asia. Its business model is focused on providing a wide range of instruments, devices, and services for research, diagnostics, and therapy in the medical industry. The company designs and produces its own products and also offers customized solutions for customers. It is divided into different divisions, including instruments and devices for molecular biology and diagnostics, cell analysis, microscopy, and sample processing. They offer products such as PCR systems, qPCR systems, automated sample preparation systems, and RNA isolation kits for molecular biology and diagnostics. They also produce cell counting systems, flow cytometers, high-speed imaging systems, multi-well plate readers for cell analysis. In the microscopy division, the company manufactures high-quality fluorescence microscopes and deconvolution microscopes for protein and DNA molecule analysis, disease diagnostics, drug development, etc. In the sample processing division, they produce automated stations used for preparing samples for genomics and proteomics analysis. The company is also engaged in research and development of medical devices and instruments to improve the quality of medical diagnostics and therapy. A successful product example is the qPCR thermocycler MIQE used in the diagnosis and therapy of diseases like cancer. Precision System Science Co Ltd has played a significant role in fighting the COVID-19 pandemic by producing test kits for diagnosis and offering advanced PCR systems for mass testing. They are committed to continuous innovation and improvement of their products and services to meet the changing needs of the medical industry. With their strong presence and dedication to providing state-of-the-art and innovative products and services, they will remain a major player in the global market for medical devices and instruments. Precision System Science Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Precision System Science Co's Equity

Precision System Science Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Precision System Science Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Precision System Science Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Precision System Science Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Precision System Science Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Precision System Science Co stock

The Equity of Precision System Science Co is 3.76 B JPY in 2026.

Access this data via the Eulerpool API

Balance Sheet — Precision System Science Co

All Key Metrics — Precision System Science Co